KBC Group’s Dynavax Technologies DVAX Stock Holding History

KBC Group’s Portfolio DVAX Stock Details DVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-7,016	Closed	-$91K	–	1742
2025 Q1	$91K	Hold	7,016	–	–	﹤0.01%	1533
2024 Q4	$90K	Buy	7,016 +2,857	+69%	+$34.6K	﹤0.01%	1625
2024 Q3	$46K	Hold	4,159	–	–	﹤0.01%	1744
2024 Q2	$47K	Hold	4,159	–	–	﹤0.01%	1650
2024 Q1	$52K	Hold	4,159	–	–	﹤0.01%	1535
2023 Q4	$58K	Hold	4,159	–	–	﹤0.01%	1410
2023 Q3	$61K	Sell	4,159 -5,406	-57%	-$76K	﹤0.01%	1301
2023 Q2	$124K	Hold	9,565	–	–	﹤0.01%	1106
2023 Q1	$94K	Hold	9,565	–	–	﹤0.01%	1219
2022 Q4	$102K	Hold	9,565	–	–	﹤0.01%	1186
2022 Q3	$100K	Buy	+9,565	New	+$125K	﹤0.01%	1187
2019 Q2	–	Sell	-4,500	Closed	-$33K	–	1470
2019 Q1	$33K	Hold	4,500	–	–	﹤0.01%	1346
2018 Q4	$41K	Hold	4,500	–	–	﹤0.01%	1230
2018 Q3	$56K	Hold	4,500	–	–	﹤0.01%	1325
2018 Q2	$69K	Hold	4,500	–	–	﹤0.01%	1206
2018 Q1	$89K	Buy	4,500 +800	+22%	+$13.8K	﹤0.01%	1190
2017 Q4	$69K	Buy	+3,700	New	+$74.3K	﹤0.01%	1193

Other funds holding DVAX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

KBC Group's DVAX Position: Q2 2025 in Review

KBC Group sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 7,016 shares — an estimated $91K sold.

KBC Group first reported a position in DVAX in Q4 2017 and held it in 17 quarters. The position peaked at $124K in Q2 2023. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

KBC Group reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
KBC Group sold 7,016 Dynavax Technologies shares in Q2 2025, an estimated $91K.
KBC Group first reported a position in Dynavax Technologies in Q4 2017 and held it in 17 quarters.
KBC Group's Dynavax Technologies position peaked at $124K in Q2 2023.
268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on KBC Group's 13F filing for Q2 2025, filed 8 Aug 2025.